Silara Medtech

The shareholders of Silara Medtech are the actual controllers of Haisco Pharmaceutical Group. The company's technical team mainly comes from well-known domestic and international enterprises such as Medtronic, Edwards, and Hangzhou Qiming, with an average of 15 years of working experience in the cardiac valve field. The company’s product is the world’s only non-metallic (polymer) bovine pericardial TAVR device, with postoperative paravalvular leakage being only one-third of that of international peers, and it closely collaborates with eight authoritative TAVR hospitals in China. It is reported that Silara plans to go public in Hong Kong as an independent medical technology company, striving to become a leading enterprise in China’s structural heart disease device field.